Carolyn E Shembrey 36th Lorne Cancer Conference 2024

Abstracts this author is presenting:

• Harnessing CRISPR-Cas13 for selective ablation of point-mutated oncogenes with single-nucleotide precision — Session 4: Cancer Drivers/Cell Signalling